ImmunityBio Inc. (IBRX)
NASDAQ: IBRX
· Real-Time Price · USD
2.49
-0.02 (-0.80%)
At close: May 01, 2025, 3:59 PM
2.48
-0.40%
After-hours: May 01, 2025, 06:31 PM EDT
ImmunityBio Revenue
ImmunityBio reported an annual revenue of $14.74M, reflecting a 2270.58% growth. For the quarter ending December 31, 2024, ImmunityBio generated $7.55M in revenue.
Revenue (ttm)
$14.74M
Revenue Growth
2270.58%
Price / Sales Ratio
121.07
Revenue / Employee
$21.68K
Employees
680
Market Cap
2.2B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 14.74M | +2270.58% |
| Dec 31, 2023 | 622K | +159.17% |
| Dec 31, 2022 | 240K | -74.30% |
| Dec 31, 2021 | 934K | +54.38% |
| Dec 31, 2020 | 605K | n/a |